Your browser doesn't support javascript.
loading
Epidemiology of acute myeloid leukemia in Virginia: Excellent survival outcomes for patients in rural Appalachia.
Isaac, Krista M; Reed, Daniel R; Desai, Raj Piyush; Williams, Eli; Balkrishnan, Rajesh; Keng, Michael K; Ballen, Karen K.
Afiliação
  • Isaac KM; Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, Virginia, USA.
  • Reed DR; Section on Hematology/Oncology, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA.
  • Desai RP; Cancer Population Health Core, University of Virginia Cancer Center, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
  • Williams E; Department of Pathology, University of Virginia Health System, Charlottesville, Virginia, USA.
  • Balkrishnan R; Cancer Population Health Core, University of Virginia Cancer Center, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
  • Keng MK; Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, Virginia, USA.
  • Ballen KK; Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, Virginia, USA.
Cancer Rep (Hoboken) ; 4(4): e1354, 2021 08.
Article em En | MEDLINE | ID: mdl-33751859
BACKGROUND: Acute myeloid leukemia, the most common acute leukemia in adults, has a poor overall survival. Studies have suggested that certain socioeconomic factors such as living in a rural or farming area are associated with worse outcomes. Since 42% of acute myeloid leukemia patients seen in our academic center reside in a rural area, we have a unique opportunity to study outcomes of patients in rural versus urban settings. AIM: This analysis evaluates the effect of geography and socioeconomic factors on the biology, treatment, and overall survival of patients with acute myeloid leukemia, with the goal of understanding health care disparities. METHODS AND RESULTS: Patient characteristics, cytogenetic data, treatment history, and overall survival were collected and analyzed to identify differences between urban and rural residency. This cohort included 42% of patients who resided in a rural area at the time of acute myeloid leukemia diagnosis. There was no difference in overall survival between the cohorts. The 1 year overall survival for the entire cohort was 47.9%. There was no difference detected in rates of adverse cytogenetics between the rural and urban cohorts. Similar numbers of patients received induction chemotherapy or proceeded to allogeneic stem cell transplant between the cohorts. CONCLUSIONS: This study highlights that similar outcomes can be achieved in rural and urban patients, suggesting that intensive efforts at telehealth, education, and collaboration with local oncology practices may be beneficial.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: População Rural / População Urbana / Leucemia Mieloide Aguda Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Determinantes_sociais_saude Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Rep (Hoboken) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: População Rural / População Urbana / Leucemia Mieloide Aguda Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Determinantes_sociais_saude Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Rep (Hoboken) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos